Regulatory Trends in Global DTx Approval

Navigating the regulatory landscape for digital therapeutics is essential to ensuring global adoption, safety, and reimbursement. Regulatory bodies such as the FDA, EMA, and others are actively shaping new pathways to evaluate software-based medical interventions. As DTx products differ from traditional pharmaceuticals and medical devices, establishing standards for efficacy, cybersecurity, usability, and clinical validation is crucial. Globally, regulatory frameworks are evolving to address software as a medical device (SaMD), with increasing clarity on documentation, real-world evidence, and risk stratification. Harmonization across countries remains a challenge, but recent developments signal progress toward global conformity. This session explores the nuances of obtaining regulatory approval for DTx, with case examples from the U.S., Europe, and Asia-Pacific markets. It will address the role of clinical trials, regulatory sandboxes, AI regulation, and post-market surveillance in shaping policy. Attendees will gain practical insights into navigating international regulatory processes to bring compliant, scalable, and safe DTx solutions to market.

    Related Conference of Regulatory Trends in Global DTx Approval

    January 28-29, 2026

    43rd International Conference on Women's Health

    Bangkok, Thailand
    February 16-17, 2026

    11th World Congress on Public Health and Nutrition

    Paris, France
    March 09-10, 2026

    6th International conference on Healthcare Summit

    Paris, France
    March 12-13, 2026

    8th International Conference on Digital Health

    London, UK
    April 08-09, 2026

    5th International Congress on Global Healthcare

    Vienna, Austria
    April 13-14, 2026

    31st International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    April 20-21, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    April 27-28, 2026

    8th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    June 01-02, 2026

    2nd International Congress on Primary Health and Safety

    Zurich, Switzerland
    June 15-16, 2026

    8th World Conference on Vaccine and Immunology

    Paris, France
    July 13-14, 2026

    13th World congress on Hospice and Palliative care

    Amsterdam, Netherlands
    July 23-24, 2026

    37th European Heart and Heart Failure Congress

    Paris, France
    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands

    Regulatory Trends in Global DTx Approval Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in